Shih Chieh Chang

Biochemistry, Genetics and Molecular Biology · Life Sciences

8h-index461citations26works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ion channel regulation and function(5), Ubiquitin and proteasome pathways(5), Protein Degradation and Inhibitors(5), Nicotinic Acetylcholine Receptors Study(4), VLSI and Analog Circuit Testing(3)

Publications26 total

Targeted degradation of PCNA outperforms stoichiometric inhibition to result in programed cell death
Cell chemical biology·2022· 28 cited
STUB1 is an intracellular checkpoint for interferon gamma sensing
Scientific Reports·2022· 12 citedOpen Access
Targeted degradation of PCNA outperforms stoichiometric inhibition to result in programed cell death
2022Open Access
Targeted Degradation of PCNA Outperforms Stoichiometric Inhibition to Result in Programed Cell Death
SSRN Electronic Journal·2022Open Access
STUB1 is an intracellular checkpoint for interferon gamma sensing
2020· 3 citedOpen Access
CD4+ T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized Mice
Frontiers in Immunology·2020· 92 citedOpen Access
Modulation of Lymphocyte Potassium Channel K<sub>V</sub>1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant Defensin
ACS Pharmacology & Translational Science·2020· 24 citedOpen Access
bioPROTACs as versatile modulators of intracellular therapeutic targets including proliferating cell nuclear antigen (PCNA)
Proceedings of the National Academy of Sciences·2020· 158 citedOpen Access
bioPROTACs as versatile modulators of intracellular therapeutic targets: Application to proliferating cell nuclear antigen (PCNA)
2019Open Access
Structure of Lymphocyte Potassium Channel K &lt;sub&gt;v&lt;/sub&gt;1.3 and Modulation by Cell-Penetrating Immunomodulatory Plant Defensin
SSRN Electronic Journal·2019Open Access
ShK toxin: history, structure and therapeutic applications for autoimmune diseases
WikiJournal of Science·2018· 8 citedOpen Access
Novel potassium channel blockers for the treatment of multiple sclerosis and other autoimmune diseases
Monash University·2017Open Access
Novel potassium channel blockers for the treatment of multiple sclerosis and other autoimmune diseases
Figshare·2017· 1 citedOpen Access
Novel potassium channel blockers for the treatment of multiple sclerosis and other autoimmune diseases
Monash University·2017Open Access
The application of active notification medical procedure for the assistance of elderly patients
2016
Cover Picture: Conformational Flexibility in the Binding Surface of the Potassium Channel Blocker ShK (ChemBioChem 16/2014)
ChemBioChem·2014Open Access
Conformational Flexibility in the Binding Surface of the Potassium Channel Blocker ShK
ChemBioChem·2014· 18 citedOpen Access
Kv1.3 channel‐blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases
The FASEB Journal·2014· 88 citedOpen Access
Kv1.3-Blocking Peptides from Parasitic Worms Exhibit Immunomodulatory Function
Biophysical Journal·2014Open Access
Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria
Toxicon·2012· 21 cited
page 1 of 2Next →

Frequent Co-authors

Shuhui Lim(7), Simon Ng(7), Brian Henry(7), Anthony W. Partridge(7), Raymond S. Norton(7), Christine Beeton(5), Michael W. Pennington(5), Pooja Gopal(5), Ruban Mangadu(5), Uyen Phan(5), Sandeep Chhabra(4), Hai M. Nguyen(4), Mark R. Tanner(4), K. George Chandy(3), Vikas Dhawan(3), Heike Wulff(3), Arun Chandramohan(3), Jeffrey S. Smith(3), Marian E. Gindy(3), Saumya Bajaj(3)